Pasar al contenido principal

NUEVAS HERRAMIENTAS NANOTECNOLOGICAS EN EL TRATAMIENTO DE PATOLOGIA NEUROINFLAMATORIA Y SU INTERACCION CON EL EJE INTESTINO-CEREBRO

PID2021-128862OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA INVESTIGACION BIOMEDICA HOSPITAL G. MARAÑON

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Absolute Quantification and Spatial Mapping of Hyaluronic Acid in Histological Tissue Sections

  • Quilez López, Cristina
  • González-Rico Iriarte, Jorge
  • López Donaire, Maria Luisa
  • Gago López, Nuria
  • Muñoz Barrutia, María Arrate
  • Velasco Bayón, Diego
We present an accessible methodology for the absolute quantification and spatial mapping of hyaluronic acid (HA) in paraffin-embedded tissues. Although HA plays critical roles in tissue hydration, organization, and disease progression, its local concentration and spatial distribution remain poorly defined due to the lack of quantitative measurement tools. By integrating immunofluorescence, ELISA, and image analysis our approach enables the generation of pixel-level HA concentration maps. This strategy bridges the gap between qualitative imaging modalities and bulk biochemical assays, offering both spatial resolution and quantitative data. The method is validated across multiple tissues and is robust, scalable, and readily applicable to other extracellular matrix components, offering a practical tool for studying tissue microenvironments in health, disease, and biomaterial design., We present an accessible methodology for the absolute quantification and spatial mapping of hyaluronic acid (HA) in paraffin-embedded tissues. Although HA plays critical roles in tissue hydration, organization, and disease progression, its local concentration and spatial distribution remain poorly defined due to the lack of quantitative measurement tools. By integrating immunofluorescence, ELISA, and image analysis our approach enables the generation of pixel-level HA concentration maps. This strategy bridges the gap between qualitative imaging modalities and bulk biochemical assays, offering both spatial resolution and quantitative data. The method is validated across multiple tissues and is robust, scalable, and readily applicable to other extracellular matrix components, offering a practical tool for studying tissue microenvironments in health, disease, and biomaterial design.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Unraveling the potential of hypothalamic deep brain stimulation for obesity: Impacts on memory, neuroplasticity and brain metabolism in the Zucker rat

  • Casquero Veiga, Marta
  • Llorca Torrarba, Meritxell
  • Bueno Fernández, Clara
  • Romero Miguel, Diego
  • Lamanna Rama, Nicolás
  • Winter, Christine
  • Berrocoso, Esther
  • Nacher, Juan
  • Desco Menéndez, Manuel
  • Soto Montenegro, María Luisa
The lateral hypothalamus (LH) plays a key role in regulating energy balance and appetite, making it a potential target for deep brain stimulation (DBS) in treatment-resistant obesity. In this study, we evaluated the short and long-term in vivo effects of continuous LH-DBS over 15 days in a genetic model of obesity: the Zucker rat. We examined changes in body weight, brain glucose metabolism (via positron emission tomography, PET), and memory performance, along with ex vivo neuroplasticity in different hippocampal layers one month post-treatment. Contrary to expectations, continuous LH-DBS did not reduce the weight gain or food intake. While stimulated rats exhibited hippocampal hypermetabolism and enhanced synaptogenesis, these changes did not translate into cognitive improvements. Interestingly, long-term memory benefits were observed in all animals that underwent surgery, regardless of whether they received stimulation. In conclusion, our results do not support continuous LH-DBS as an effective treatment to reduce body weight in cases of obesity with genetic leptin resistance. However, the hippocampal modulation induced by continuous LH-DBS shows potential for addressing cognitive impairments associated with leptin resistance. These findings suggest that alternative DBS protocols may help restore hippocampal function, warranting further investigation., We thank Esther Rodríguez-Flores for her support in neuroplasticity data collection. MLS was supported by Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (project number PI17/01766, and grant number BA21/00030), co-financed by the European Regional Development Fund (ERDF), “A way of making Europe”; project PID2021-128862OB-I00 funded by MCIN /AEI /10.13039/501100011033 / FEDER, UE; CIBER de Salud Mental - Instituto de Salud Carlos III (project number CB07/09/0031); Delegación del Gobierno para el Plan Nacional sobre Drogas (project number 2017/085, Project number 2024I090); Delegación del Gobierno para el Plan Nacional sobre Drogas correspondiente a fondos del Mecanismo de Recuperación, Transformación y Resiliencia de la Unión Europea (EXP2022/008917), II Edición de Ayudas a la Investigación en Nutrición de iSanidad-Herbalife, and Fundación Mapfre. MCV was supported by Fundación Tatiana Pérez de Guzmán el Bueno as scholarship holder of this institution. DRM was supported by Consejería de Educación e Investigación, Comunidad de Madrid, co-funded by European Social Fund “Investing in your future” (grant number PEJD-2018-PRE/BMD-7899). NLR was supported by Instituto de Investigación Sanitaria Gregorio Marañón, “Programa Intramural de Impulso a la I+D+I 2019”. MD work was supported by Ministerio de Ciencia e Innovación (MCIN) and Instituto de Salud Carlos III (PT23/00027). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV‐2015‐0505). MLT and EB were supported by grants: co-financed by the “Fondo Europeo de Desarrollo Regional” (FEDER)-UE “A way to build Europe” from the “Ministerio de Economía y Competitividad” (project number MINECO: RTI2018-099778-B-I00); from the “Plan Nacional sobre Drogas, Ministerio de Sanidad, Consumo y Bienestar Social” (project number 2019I041); from the “Programa Operativo de Andalucía FEDER, Iniciativa Territorial Integrada ITI 2014-2020 Consejería Salud, Junta de Andalucía” (projects numbers PI-0080-2017 and PI-0009-2017); from the “Consejería de Salud de la Junta de Andalucía” (project number PI-0134-2018); from the University of Cádiz (project number PR2019-046); from the “Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz-INiBICA” (project number IN-C09); from the “Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía” (grant number CTS-510); from the “CIBERSAM” (project number CB07/09/0033). Support for Nacher’s lab came from Ministry of Economy and Competitiveness (project number RTI2018-095698-B-I00) and Generalitat Valenciana (project number PROMETEO2020/024).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Unraveling the potential of hypothalamic deep brain stimulation for obesity: Impacts on memory, neuroplasticity and brain metabolism in the Zucker rat

  • Casquero-Veiga, Marta
  • Llorca Torralba, Meritxell
  • Bueno-Fernandez, C.
  • Romero-Miguel, Diego
  • Lamanna-Rama, Nicolás
  • Winter, C.
  • Berrocoso Domínguez, Esther María
  • Nacher, Juan
  • Desco, Manuel
  • Soto-Montenegro, María Luisa
The lateral hypothalamus (LH) plays a key role in regulating energy balance and appetite, making it a potential target for deep brain stimulation (DBS) in treatment-resistant obesity. In this study, we evaluated the short and long-term in vivo effects of continuous LH-DBS over 15 days in a genetic model of obesity: the Zucker rat. We examined changes in body weight, brain glucose metabolism (via positron emission tomography, PET), and memory performance, along with ex vivo neuroplasticity in different hippocampal layers one month post-treatment. Contrary to expectations, continuous LH-DBS did not reduce the weight gain or food intake. While stimulated rats exhibited hippocampal hypermetabolism and enhanced synaptogenesis, these changes did not translate into cognitive improvements. Interestingly, long-term memory benefits were observed in all animals that underwent surgery, regardless of whether they received stimulation. In conclusion, our results do not support continuous LH-DBS as an effective treatment to reduce body weight in cases of obesity with genetic leptin resistance. However, the hippocampal modulation induced by continuous LH-DBS shows potential for addressing cognitive impairments associated with leptin resistance. These findings suggest that alternative DBS protocols may help restore hippocampal function, warranting further investigation.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

  • Romero-Miguel, D.
  • Casquero-Veiga, M.
  • Lamanna-Rama, N.
  • Torres Sánchez, Sonia
  • MacDowell, K.S.
  • García Partida, José Antonio
  • Santa-Marta, C.
  • Berrocoso Domínguez, Esther María
  • Leza, J.C.
  • Desco, M.
  • Soto-Montenegro, M.L.
Schizophrenia is a chronic neurodevelopmental disorder with an inflammatory/prooxidant component. N-acetylcysteine (NAC) has been evaluated in schizophrenia as an adjuvant to antipsychotics, but its role as a preventive strategy has not been sufficiently explored. We aimed to evaluate the potential of NAC administration in two-time windows before the onset of symptoms in a schizophrenia-like maternal immune stimulation (MIS) rat model. Pregnant Wistar rats were injected with Poly I:C or Saline on gestational day (GD) 15. Three different preventive approaches were evaluated: 1) NAC treatment during periadolescence in the offspring (from postnatal day [PND] 35 to 49); 2) NAC treatment during pregnancy after MIS challenge until delivery (GD15–21); and 3) NAC treatment throughout all pregnancy (GD1–21). At postnatal day (PND) 70, prepulse inhibition (PPI) and anxiety levels were evaluated. In vivo magnetic resonance (MR) imaging was acquired on PND100 to assess structural changes in gray and white matter, and brain metabolite concentrations. Additionally, inflammation and oxidative stress (IOS) markers were measured ex vivo in selected brain regions. MIS offspring showed behavioral, neuroanatomical, and biochemical alterations. Interestingly, NAC treatment during periadolescence prevented PPI deficits and partially counteracted some biochemical imbalances. Moreover, NAC treatments during pregnancy not only replicated the beneficial outcomes reported by the treatment in periadolescence, but also prevented some neuroanatomical deficits, including reductions in hippocampal and corpus callosum volumes. This study suggests that early reduction of inflammation and prooxidation could help prevent the onset of schizophrenia-like symptoms, supporting the importance of anti-IOS compounds in ameliorating this disorder., 15 páginas
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maternal Supplementation with N-Acetylcysteine Modulates the Microbiota-Gut-Brain Axis in Offspring of the Poly I:C Rat Model of Schizophrenia

  • Romero-Miguel, Diego
  • Casquero-Veiga, Marta
  • Fernández, Javier
  • Lamanna-Rama, Nicolas
  • Gómez-Rangel, Vanessa
  • Gálvez-Robleño, Carlos
  • Santa-Marta, Cristina
  • Villar, Claudio J.
  • Lombó, Felipe
  • Abalo, Raquel
  • Desco, Manuel
  • Soto-Montenegro, María Luisa
The microbiota-gut-brain axis is a complex interconnected system altered in schizophrenia. The antioxidant N-acetylcysteine (NAC) has been proposed as an adjunctive therapy to antipsychotics in clinical trials, but its role in the microbiota-gut-brain axis has not been sufficiently explored. We aimed to describe the effect of NAC administration during pregnancy on the gut-brain axis in the offspring from the maternal immune stimulation (MIS) animal model of schizophrenia. Pregnant Wistar rats were treated with PolyI:C/Saline. Six groups of animals were studied according to the study factors: phenotype (Saline, MIS) and treatment (no NAC, NAC 7 days, NAC 21 days). Offspring were subjected to the novel object recognition test and were scanned using MRI. Caecum contents were used for metagenomics 16S rRNA sequencing. NAC treatment prevented hippocampal volume reduction and long-term memory deficits in MIS-offspring. In addition, MIS-animals showed lower bacterial richness, which was prevented by NAC. Moreover, NAC7/NAC21 treatments resulted in a reduction of proinflammatory taxons in MIS-animals and an increase in taxa known to produce anti-inflammatory metabolites. Early approaches, like this one, with anti-inflammatory/anti-oxidative compounds, especially in neurodevelopmental disorders with an inflammatory/oxidative basis, may be useful in modulating bacterial microbiota, hippocampal size, as well as hippocampal-based memory impairments., M.L.S.-M. was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (project number PI17/01766, and grant number BA21/00030), co-financed by the European Regional Development Fund (ERDF), “A way to make Europe”; project PID2021-128862OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, CIBER de Salud Mental-Instituto de Salud Carlos III (project number CB07/09/0031); Delegación del Gobierno para el Plan Nacional sobre Drogas (project number 2017/085, 2022/008917); and Fundación Alicia Koplowitz. D.R.-M. was supported by Consejería de Educación e investigación, Comunidad de Madrid, co-funded by the European Social Fund “Investing in your future” (grant, PEJD-2018-PRE/BMD-7899). M.C.-V. was supported by a predoctoral grant from Fundación Tatiana Pérez de Guzmán el Bueno. N.L.-R. was supported by the Instituto de investigación Sanitaria Gregorio Marañón, “Programa Intramural de Impulso a la I+D+I 2019”. V.G.-R was supported by Consejería de Educación e investigación, Comunidad de Madrid, co-funded by the European Social Fund “Investing in your future” (grant, PEJD-2017-TL/BMD-7385). C.G.-R. was supported by Universidad Rey Juan Carlos (PREDOC20-054). R.A. was supported by Ministerio de Ciencia, Innovación y Universidades (grant number PID2019-111510RB-I00) and Grupo Español de Motilidad Digestiva (Beca Allergan, 2017). M.D. work was supported by Ministerio de Ciencia e Innovación (MCIN) and Instituto de Salud Carlos III (PT20/00044). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). J.F. was supported by “Contrato Intramural Postdoctoral” from FINBA (Principado de Asturias, Spain). F.L. was supported by Ayudas para grupos de investigación de organismos del Principado de Asturias (SV-PA-21-AYUD/2021/51347)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Data from: Field Assessment of Biochar Interactions with Chemical and Biological N Fertilization in Pointed White Cabbage

  • Castejón-del Pino, Raúl
  • Cayuela, María Luz
  • Sánchez García, María
  • Siles Martos, José Antonio
  • Sánchez-Monedero, Miguel Ángel
This dataset is associated with the manuscript entitled "Field Assessment of Biochar Interactions with Chemical and Biological N Fertilization in Pointed White Cabbage"., We gratefully acknowledge the financial support of the project PID2021-12886OB100 funded by MCIN/AEI /10.13039/501100011033/ and ERDF A way of making Europe. R. Castejón-del Pino was supported by the grant PRE2019-088308 funded by MICIU/ AEI /10.13039/501100011033 and ESF Investing in your future within the project RTI2018-099417-BI00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In-depth 3D exploration of autosomal dominant polycystic kidney disease through light sheet fluorescence microscopy

  • Delgado-Rodriguez, Pablo
  • Vitoria, Itsaso
  • Ríos-Muñoz, Gonzalo R
  • Bardia, Lídia
  • Lamanna-Rama, Nicolás
  • Nicolas-Saenz, Laura
  • Sporring, Jon
  • Soto-Montenegro, María L
  • Aldabe, Rafael
  • Colombelli, Julien
  • Muñoz-Barrutia, Arrate
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent genetic kidney disorder. Animal preclinical studies are one of the main tools to study this disease, often through either 2D histology imaging for high-resolution analysis or CT or MRI for full kidney segmentation. As an alternative to these modalities, we propose the use of Light Sheet Fluorescence Microscopy (LSFM) for high-resolution 3D imaging of healthy and ADPKD-induced mouse kidneys, enabling a detailed volumetric morphological analysis of the disease's effects. In a mouse ADPKD model, ex vivo imaging of the kidneys was performed through LSFM, after which a combination of machine learning and other processing techniques allowed us to perform an in-depth image analysis. This includes the segmentation of key structures, such as the full kidney volume and, within it, its internal cavities, cortex, glomeruli, and cysts, complemented by texture analysis of tubular structures in the cortical area. Pathological kidneys exhibited significant volume enlargement and increased internal cavities due to cystogenesis. While glomerular count remained stable, their spatial distribution was altered, showing increased interglomerular distances and showcasing the deformations produced by the disease. The texture analysis of tubules from the cortex region identified Local Binary Pattern (LBP) uniformity and porosity as key biomarkers of tissue deformation, which could be used as markers to further evaluate the development of the disease. These findings underscore the potential of LSFM imaging as a powerful tool for detailed ADPKD characterization and treatment assessment., This work was partially funded by Ministerio de Ciencia, Innovación y Universidades, through an FPU fellowship (FPU19/02854) granted to PDR; also by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033/), under Grants PID2021-128862OB-I00 (to MLMS), PID2023-152631OB-I00 (to AMB), and RTC-2017-6600-1 (to AMB), co-financed by European Regional Development Fund (ERDF), ”A way of making Europe”. The project received support from Grant 0011-1411- 2019-000074 (to RA), from proyectos de I+D estratégicos (RIS3), Departamento de Desarrollo Económico del Gobierno de Navarra. It was also partially funded by CIBER de Salud Mental - ISCIII (project number CB07/09/0031) (to MLSM); Delegación del Gobierno para el Plan Nacional sobre Drogas, corresponding to funds of the NextGenerationEU Recovery and Resilience Facility (EXP2022/008917) (to MLSM); and Delegación del Gobierno para el Plan Nacional sobre Drogas (2024I090) (to MLSM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unraveling the potential of hypothalamic deep brain stimulation for obesity: Impacts on memory, neuroplasticity and brain metabolism in the Zucker rat

  • Casquero-Veiga, Marta
  • Llorca-Torralba, Meritxell
  • Bueno-Fernandez, Clara
  • Romero-Miguel, Diego
  • Lamanna-Rama, Nicolás
  • Winter, Christine
  • Berrocoso, Esther
  • Nacher, Juan
  • Desco, Manuel
  • Soto-Montenegro, Mª Luisa
The lateral hypothalamus (LH) plays a key role in regulating energy balance and appetite, making it a potential target for deep brain stimulation (DBS) in treatment-resistant obesity. In this study, we evaluated the short and long-term in vivo effects of continuous LH-DBS over 15 days in a genetic model of obesity: the Zucker rat. We examined changes in body weight, brain glucose metabolism (via positron emission tomography, PET), and memory performance, along with ex vivo neuroplasticity in different hippocampal layers one month post-treatment. Contrary to expectations, continuous LH-DBS did not reduce the weight gain or food intake. While stimulated rats exhibited hippocampal hypermetabolism and enhanced synaptogenesis, these changes did not translate into cognitive improvements. Interestingly, long-term memory benefits were observed in all animals that underwent surgery, regardless of whether they received stimulation. In conclusion, our results do not support continuous LH-DBS as an effective treatment to reduce body weight in cases of obesity with genetic leptin resistance. However, the hippocampal modulation induced by continuous LH-DBS shows potential for addressing cognitive impairments associated with leptin resistance. These findings suggest that alternative DBS protocols may help restore hippocampal function, warranting further investigation., We thank Esther Rodríguez-Flores for her support in neuroplasticity data collection. MLS was supported by Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (project number PI17/01766, and grant number BA21/00030), co-financed by the European Regional Development Fund (ERDF), “A way of making Europe”; project PID2021-128862OB-I00 funded by MCIN /AEI /10.13039/501100011033 / FEDER, UE; CIBER de Salud Mental - Instituto de Salud Carlos III (project number CB07/09/0031); Delegación del Gobierno para el Plan Nacional sobre Drogas (project number 2017/085, Project number 2024I090); Delegación del Gobierno para el Plan Nacional sobre Drogas correspondiente a fondos del Mecanismo de Recuperación, Transformación y Resiliencia de la Unión Europea (EXP2022/008917), II Edición de Ayudas a la Investigación en Nutrición de iSanidad-Herbalife, and Fundación Mapfre. MCV was supported by Fundación Tatiana Pérez de Guzmán el Bueno as scholarship holder of this institution. DRM was supported by Consejería de Educación e Investigación, Comunidad de Madrid, co-funded by European Social Fund “Investing in your future” (grant number PEJD-2018-PRE/BMD-7899). NLR was supported by Instituto de Investigación Sanitaria Gregorio Marañón, “Programa Intramural de Impulso a la I+D+I 2019”. MD work was supported by Ministerio de Ciencia e Innovación (MCIN) and Instituto de Salud Carlos III (PT23/00027). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV‐2015‐0505). MLT and EB were supported by grants: co-financed by the “Fondo Europeo de Desarrollo Regional” (FEDER)-UE “A way to build Europe” from the “Ministerio de Economía y Competitividad” (project number MINECO: RTI2018-099778-B-I00); from the “Plan Nacional sobre Drogas, Ministerio de Sanidad, Consumo y Bienestar Social” (project number 2019I041); from the “Programa Operativo de Andalucía FEDER, Iniciativa Territorial Integrada ITI 2014-2020 Consejería Salud, Junta de Andalucía” (projects numbers PI-0080-2017 and PI-0009-2017); from the “Consejería de Salud de la Junta de Andalucía” (project number PI-0134-2018); from the University of Cádiz (project number PR2019-046); from the “Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz-INiBICA” (project number IN-C09); from the “Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía” (grant number CTS-510); from the “CIBERSAM” (project number CB07/09/0033). Support for Nacher’s lab came from Ministry of Economy and Competitiveness (project number RTI2018-095698-B-I00) and Generalitat Valenciana (project number PROMETEO2020/024)., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Sin experimentacion animal ni uso de NAMs, Mamíferos - Roedores
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prenatal omega-3 fatty acids supplementation mitigates some schizophrenia-like deficits in offspring: A PET and MRI study in a rat model

  • Diego Romero-Miguel
  • Marta Casquero-Veiga
  • Nicolás Lamanna-Rama
  • Raquel Chávez-Valencia
  • Vanessa Gómez-Rangel
  • Ravit Hadar
  • Christine Winter
  • Manuel Desco
  • María Luisa Soto-Montenegro
Omega-3 fatty acids (OM) have been employed as adjunctive therapy in patients with schizophrenia, but their potential as a preventive strategy remains unclear. This study aims to evaluate whether dietary OM supplementation during pregnancy may prevent schizophrenia-like deficits in a maternal immune stimulation (MIS) model. Pregnant Wistar rats were injected with PolyI:C (i.e. MIS) or Saline on gestational day 15. They were fed with OM-enriched chow, either from MIS until delivery (OM7) or throughout gestation (OM21). Two control groups (Saline-naïve & MIS-naïve) were maintained on standard chow. In adulthood, offspring were assessed through tests for locomotion, anxiety and short- and long-term memory (STM, LTM). Brain glucose metabolism and structural in vivo neuroimaging studies were performed using PET and MRI techniques. OM7/OM21 treatments prevented the hyperlocomotion in MIS-offspring while STM deficits were only improved by OM7. Both OM7/OM21 treatments prevented certain metabolic and volumetric changes in the cortex, as well as the enlargement of the ventricles. Additionally, OM21 protected WM integrity in MIS-offspring. Altogether, our study highlights the potential of prenatal OM dietary supplementation to ameliorate some of the SCZ-like deficits observed in the MIS model., MLS was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (project number PI17/01766, and grant number BA21/00030), co-financed by the European Regional Development Fund (ERDF), “A way to make Europe”; project PID2021-128862OB-I00 funded by MCIN /AEI /10.13039/501100011033 / FEDER, UE; CIBER de Salud Mental - Instituto de Salud Carlos III (project number CB07/ 09/0031); Delegación del Gobierno para el Plan Nacional sobre Drogas (project number 2017/085, 2024I090); and Delegacion del Gobierno para el Plan Nacional sobre Drogas correspondiente a fondos del Mecanismo de Recuperacion, Transformacion y Resiliencia de la Union Europea (EXP2022/008917). DRM was supported by Consejería de Educación e investigación, Comunidad de Madrid, co-funded by the European Social Fund “Investing in your future” (grant, PEJD-2018-PRE/BMD-7899). MCV was supported by a predoctoral grant from Fundación Tatiana Pérez de Guzmán el Bueno. NLR was supported by the Instituto de investigación Sanitaria Gregorio Marañón, “Programa Intramural de Impulso a la I + D + I 2019”. MD work was supported by Ministerio de Ciencia e Innovación (MCIN) and Instituto de Salud Carlos III (PT23/00027). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)., Peer reviewed